Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001354488-13-003320
Filing Date
2013-06-05
Accepted
2013-06-05 16:10:24
Documents
6
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 tbuff_10ka.htm 10-K/A 108750
2 LOAN AND SECURITY AGREEMENT tbuff_ex1037.htm EX-10.37 764858
3 CERTIFICATION tbuff_ex311.htm EX-31.1 12216
4 CERTIFICATION tbuff_ex312.htm EX-31.2 12005
5 CERTIFICATION tbuff_ex321.htm EX-32.1 6639
6 CERTIFICATION tbuff_ex322.htm EX-32.2 6479
  Complete submission text file 0001354488-13-003320.txt   912131
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
Tribute Pharmaceuticals Canada Inc. (Filer) CIK: 0001159019 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-31198 | Film No.: 13894370
SIC: 2834 Pharmaceutical Preparations